title: How More Types of Cancer Are Lending Themselves To Active Surveillance.
abstract: Patients and doctors are fighting the urge to rush in and treat cancer right away. Insurers must walk a fine line.
authors.forename: Richard Mark
authors.initials: RM
authors.lastname: Kirkner
mesh_terms: D003362:Cost-Benefit Analysis; D003657:Decision Making; D017048:Health Care Costs / Q000639:trends; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011159:Population Surveillance; D057285:Precision Medicine; D014481:United States; D057832:Watchful Waiting